Video Interview: Prothena Tackles Diseases Of Protein Accumulation
This article was originally published in The Pink Sheet Daily
Executive Summary
The company, spun out from Elan a few years ago, has three antibody programs focusing on diseases associated with protein accumulation in the clinic, CEO Dale Schenk notes.